SGO 2020 Annual Meeting on Women's Cancer

This conference has been CANCELLED.

The Society of Gynecologic Oncology (SGO) organizes SGO 2020 Annual Meeting on Women’s Cancer and more than 1,600 gynecologic oncologists across Toronto will attend the conference. The symposium is held from March 28-31.

Target Audience:
The session is intended mainly for gynecologic oncologists, medical oncologists, radiation oncologists, obstetricians/gynecologists, fellows and residents in the area of research scientists, nurses, nurse practitioners, physician assistants, allied health professionals and other clinicians associated with the care of patients with gynecologic malignancies.

Accreditation:
• AMA Credit Designation Statement – Physician:
This activity is approved for 26.0 AMA PRA Category 1 Credits™

• ANCC Credit Designation Statement – Nurses:
This CE activity is approved for 25.5 ANCC Contact hours

• ACPE Credit Designation Statement – Pharmacists:
This activity is approved for 21.0 ACPE contact hours (CEUs)
ACPE UAN: JA0007238-0000 (18)-006-L01 -P

On completing this session, PAs can claim a maximum of Category 1 credits (21.0). NCCPA accepts AMA PRA Category 1 Credit ™ from organizations authorized by ACCME or a recognized state or medical society

Description:
This is the premier specialty event for clinicians in the gyn onc space.

At the SGO 2020 Annual Meeting on Women’s Cancer you can:

• Join the physicians, allied professionals and researchers from all over the world who are transforming the field
• Listen to the experts in gyn onc research and treatment in curated educational sessions
• Get updates on the latest science, research and treatments; and
• Embed yourself with the updated knowledge. Implement the obtained knowledge to enhance your practice and obtain better patient outcomes.

Sign up by Jan. 13, 2020, and save up to $200 on registration.

Learning Objectives:
• Identify and evaluate the updates in global research, methods, and technology used in the treatment of gynecologic cancers
• Assess the up-to-date research findings to prevent and screen gynecologic cancers and be able to appropriately implement transitions into clinical practice by the health care providers team
• Assess the significance of the newest approaches to the medical and surgical management of gynecologic cancers within the context of the current standard of care
• Desegregating freshest therapies into clinical practice in an evidence-based manner
• Develop on the implementation of innovative approaches to the clinical care team
• Combine interdisciplinary methods to treat complex gynecologic cancers to improve outcomes
• Assess the assumptions of future research and clinical practice of the latest developments in translational research on gynecologic cancers, and
• Display the development of incompetence, performance, and patient outcomes.